mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting in California

All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials nationally

Cities in California

Recruiting trials in California

• A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
  NCT07103018 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: San Francisco
• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · California: Fountain Valley, Los Alamitos
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Los Angeles
• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · California: Duarte, La Jolla
• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07581184 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: Irvine
• Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06801236 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · California: La Jolla